Chimeric antigen receptor clustering via cysteines enhances T-cell efficacy against tumor-Reference-Cited by-同舟云学术

Chimeric antigen receptor clustering via cysteines enhances T-cell efficacy against tumor

Published:2022-04-19 Issue:11 Volume:71 Page:2801-2814
ISSN:0340-7004
Container-title:Cancer Immunology, Immunotherapy
language:en
Short-container-title:Cancer Immunol Immunother

Author:

Wang Yuedi,Gao Yiyuan,Niu Congyi,Wang Bo,Zhao Shushu,Roex Gils,Qian Jiawen,Qie Jingbo,Chen Lin,Yi Chenhe,Anguille Sébastien,Liu Jie,Luo Feifei,Chu Yiwei^ORCID

Funder

National Natural Science Foundation of China

Shanghai Rising-Star Program

Open Research Fund of State Key Laboratory of Genetic Engineering, Fudan University

Shenzhen Institute of Synthetic Biology Scientific Research Program

Senior Clinical Investigator of the Research Fund-Flanders (FWO)

Doctoral Grant Strategic Basic Research of the FWO

MeToYou Foundation

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Immunology,Immunology and Allergy

Link

https://link.springer.com/content/pdf/10.1007/s00262-022-03195-4.pdf

Reference43 articles.

1. June CH, Sadelain M (2018) Chimeric antigen receptor therapy. N Engl J Med 379:64–73. https://doi.org/10.1056/NEJMra1706169

2. Jackson HJ, Rafiq S, Brentjens RJ (2016) Driving CAR T-cells forward. Nat Rev Clin Oncol 13:370–383. https://doi.org/10.1038/nrclinonc.2016.36

3. Majzner RG, Mackall CL (2019) Clinical lessons learned from the first leg of the CAR T cell journey. Nat Med 25:1341–1355. https://doi.org/10.1038/s41591-019-0564-6

4. Hong M, Clubb JD, Chen YY (2020) Engineering CAR-T Cells for Next-Generation Cancer Therapy. Cancer Cell 38:473–488. https://doi.org/10.1016/j.ccell.2020.07.005

5. Sadelain M, Brentjens R, Riviere I (2013) The basic principles of chimeric antigen receptor design. Cancer Discov 3:388–398. https://doi.org/10.1158/2159-8290.CD-12-0548

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The method for assessing the specificity of developing CAR therapies;Biophysical Reports;2024-09

2. T cell receptor signaling and cell immunotherapy;National Science Open;2024-03-15

3. Application status and optimization suggestions of tumor organoids and CAR-T cell co-culture models;Cancer Cell International;2024-03-05

4. 3D Tumor Spheroid and Organoid to Model Tumor Microenvironment for Cancer Immunotherapy;Organoids;2022-12-05